Orange Book Blog
Author
Aaron F. Barkoff
Attorney at McDonnell Boehnen Hulbert & Berghoff LLP
OBB Newsletter
Enter your e-mail address below to subscribe to the Orange Book Blog newsletter. If a new post is added during the day, you'll receive it by e-mail the next morning.
Enter your email address:
Delivered by
FeedBurner
Event Calendar
ACI "FDA Boot Camp"
Chicago, July 21-22
CBI "3rd Summit on Biosimilars and Follow-On Biologics"
National Harbor, MD, Sept. 14-15
ACI "FDA Boot Camp"
Boston, September 15-16
IIR "Business of Biosimilars"
Boston, September 23-25
ACI "Biotech Patents"
Boston, Sept. 30 - Oct. 1
WBR BioNetwork '09
Laguna Nigel, CA, October 5-7
ACI "Maximizing Pharmaceutical Patent Life Cycles"
New York, October 7-8
CBI "Paragraph IV Disputes and Settlements"
Philadelphia, October 22-23
ACI "Pharma and Biotech Patent Opinion Writing"
Philadelphia, October 28-29
ACI "Paragraph IV On Trial"
New York, November 11-12
Discount Codes
ACI Conferences
Orange Book Blog readers save $400 on registration with THE MEDIA PARTNER DISCOUNT
CBI Conferences
Orange Book Blog readers save $400 on registration with Promo Code DTY367
Disclaimer
Orange Book Blog is published for informational purposes only; it contains no legal advice whatsoever. Publication of Orange Book Blog does not create an attorney-client relationship. Orange Book Blog is Aaron Barkoff's personal website and it is intended primarily for other attorneys. Orange Book Blog is not edited by McDonnell Boehnen Hulbert & Berghoff LLP ("MBHB") or its clients. Therefore, no part of Orange Book Blog--whether information, commentary, or other--may be attributed to MBHB or its clients. Readers should be aware that MBHB represents many companies in the pharmaceutical and biotechnology industries, and therefore Orange Book Blog may occasionally report on news that relates to MBHB clients. Orange Book Blog will always strive to be unbiased in its reporting. All information on Orange Book Blog should be double-checked for its accuracy and current applicability. -- © Aaron F. Barkoff 2006-08
Archives
July 2009
April 2009
March 2009
February 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
Categories
180-Day Exclusivity
Antitrust
Authorized Generics
Biosimilars
Citizen Petitions
Conferences
Declaratory Judgment Jurisdiction
FDA Announcements
FDA Litigation
Orange Book Patent Listing/Delisting
Other Patent Litigation (Not Para. IV)
Paragraph IV Litigation
Patent Term Extension
Pediatric Exclusivity
Pharma Business News
Section 271(e)(1) Safe Harbor
H-W Tracker
Hatch-Waxman Tracker
Search This Site
Search 32 Pharma/ Patent News Sites
Categories
180-Day Exclusivity
Antitrust
Authorized Generics
Biosimilars
Citizen Petitions
Conferences
Declaratory Judgment Jurisdiction
FDA Announcements
FDA Litigation
Orange Book Patent Listing/Delisting
Other Patent Litigation (Not Para. IV)
Paragraph IV Litigation
Patent Term Extension
Pediatric Exclusivity
Pharma Business News
Section 271(e)(1) Safe Harbor
Archives
July 2009
April 2009
March 2009
February 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
More...
Blogs
BioHealth Investor
Eye On FDA
FDA Law Blog
Holman's Biotech IP Blog
In the Pipeline
Patent Baristas
Patent Docs
Patent Prospector
Patently-O
PATracer
Peter Zura's 271 Patent Blog
Pharmalot
Spicy IP
WSJ Health Blog
FDA Resources
Citizen Petitions
Drugs@FDA
Electronic Orange Book
Exclusivity Codes
FDA Home Page
FDA Regulations
Office of Generic Drugs
Office of Orphan Products Development
Paragraph IV Certifications
Patent Resources
European Patent Office
Federal Circuit Opinions
Federal Circuit Oral Arguments
U.S. Patent and Trademark Office
USPTO Public PAIR
WIPO